Intravenous lidocaine: An outdated or underutilized treatment for pain?

Journal of Palliative Medicine

Volumn 10, Issue 3, 2007, Pages 798-805

  McCleane, Gary ^a  

^a Rampark Pain Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEXILETINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE DERIVATIVE; PARACETAMOL; PLACEBO; PROCAINE;

ANALGESIA; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG INDICATION; EVIDENCE BASED MEDICINE; HUMAN; NONHUMAN; PAIN; PALLIATIVE THERAPY; QUALITY OF LIFE; REVIEW; TERMINALLY ILL PATIENT; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INTRAVESICAL; GREAT BRITAIN; HUMANS; LIDOCAINE; PAIN; RESPIRATION, ARTIFICIAL;

EID: 34347400078     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2006.0209     Document Type: Review

References (62)

1. Butterworth JF, Strichartz GR: Molecular mechanisms of local anesthesia: A review. Anesthesiology 1990;72:711-734.
2. Taylor RE: Effect of procaine on electrical properties of squid axon membrane. Am J Physiol 1959;196:1071-1078.
3. Hille B: Common mode of action of three agents that decrease the transient change in sodium permeability in nerves. Nature 1966;210:1220-1222.
4. + channels: local anesthetics, antiarrhythmics and anticonvulsants. TIPS 1987;8:57-65.
5. Woolf CJ, Wiesenfeld-Hallin Z: The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985;23:361-374.
6. Tanelian DL, MacIver MB: Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 1991;74:934-936.
7. Devor M, Wall PD, Catalan N: Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992;48:261.
8. de Jong RH, Nace RA: Nerve impulse conduction during intravenous lidocaine injection. Anesthesiology 1968;29:22-28.
9. Zhang J-M, Li H, Munir MA: Decreasing sympathetic sprouting in pathologic sensory ganglia: A new mechanism for treating neuropathic pain using lidocaine. Pain 2004; 109:143-149.
10. Khodorova A, Meissner K, Leeson S, Strichartz GR: Lidocaine selectively blocks abnormal impulses arising from noninactivating Na channels. Muscle Nerve 2001;24:634-647.
11. Sinnott CJ, Garfield JM, Strichartz GR: Differential efficacy of intravenous lidocaine in alleviating ipsilateral versus contralateral neuropathic pain in the rat. Pain 1999; 80:521-531.
12. Abdi A, Lee DH, Chung JM: The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998;87:1360-1366.
13. Chabal C, Russell LC, Burchiel KJ: The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 1989; 38:333-338.
14. Smith LJ, Shih A, Miletic G, Miletic V: Continual systemic infusion of lidocaine provides analgesia in an animal model of neuropathic pain. Pain 2002;97:267-273.
15. Chaplan SR, Bach FW, Shafer SL, Yaksh TL: Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology 1995;83:775-785.
16. Araujo MC, Sinnott CJ, Strichartz GR: Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: Responses to early and late infusions. Pain 2003; 103:21-29.
17. Ness TJ: Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat. Anesthesiology 2000;92:1685-1691.
18. Dirks J, Fabricius P, Petersen KL, Rowbotham MC, Dahl JB. The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Anesth Analg 2000;91: 967-972.
19. Koppert W, Ostermeier N, Sittl R, Weidner C, Schmelz M: Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain 2000;85:217-224.
20. Mattsson U, Cassuto J, Tarnow P, Jösson A, Jontell M: Intravenous lidocaine infusion in the treatment of experimental human skin burns igital color image analysis of erythema development. Burns 2000;26:710-715.
21. Challapalli V, Tremont-Lukats I, McNichol E, Lau J, Carr D, Tremont-Lukats I: Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 2005;4:CD003345.
22. Tremont-Lukats IW, Challapalli V, McNichol ED, Lau J, Carr DB: Systemic administration of local anesthetics to relieve neuropathic pain: A systematic review and meta-analysis. Anesth Analg 2005;101:1738-1749.
23. Kalso E, Tramer MR, McQuay HJ, Moore RA: Systemic local-anaesthetic-type drugs in chronic pain: A systematic review. Eur J Pain 1998;2:3-14.
24. Gordon RA: Intravenous novocaine for analgesia in burns. CMAJ 1943;49:478-479.
25. Massey GV, Pedigo S, Dunn NL, Grossman NJ, Russell EC: Continuous lidocaine infusion for the relief of refractory malignant pain in a terminally ill pediatric cancer patient. J Pediatr Hematol Oncol 2002;24:566-568.
26. Thomas J, Kronenberg R, Cox MC, Naco GC, Wallace M, von Gunten CF: Intravenous lidocaine relieves severe pain: Results of an inpatient hospice chart review. J Palliat Med 2004;7:660-667.
27. Tremont-Lukats IW, Hutson PR, Backonja MM: A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain 2006;22:266-271.
28. Kastrup J, Bach FW, Petersen P, Dejgård A, Ekman R, lensen S, Angelo H: Lidocaine treatment of painful diabetic neuropathy and endogenous opioid peptides in plasma. Clin J Pain 1989;5:239-244.
29. Ackerman WE, Colclough GW, Juneja MM, Bellinger K: The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy. KMA J 1991;89:500-501.
30. Viola V, Newnham HH, Simpson RW: Treatment of intractable painful diabetic neuropathy with intravenous lidocaine. J Diabetes Complications 2006;20:34-39.
31. Kastrup J, Petersen P, Dejgård A, Angelo HR, Hilsted J: Intravenous lidocaine infusion new treatment of chronic painful diabetic neuropathy. Pain 1987;28:69-75.
32. Rowbotham MC, Reisner-Keller LA, Fields HL: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-1028.
33. Baranowski AP, De Courcey J, Bonello E: A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 1999;17:429-43.
34. Attal N, Gaudé V, Brasseur L, Dupuy M, Guirimand F, Bouhassira D: Intravenous lidocaine in central pain. A double-blind, placebo-controlled, psychophysical study. Neurology 2000;54:564-574.
35. Galer BS, Miller KV, Rowbotham MC: Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology 1993; 43:1233-1235.
36. Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D: Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 2004;62:218-225.
37. Medrik-Goldberg T, Lifschitz D, Pud D, Adler R, Eisenberg E: Intravenous lidocaine, amantadine, and placebo in the treatment of sciatica: A double-blind, randomized, controlled study. Reg Anesth Pain Med 1999;24: 534-540.
38. Wallace MS, Ridgeway BM, Leung AY, Gerayli A, Yaksh TL: Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome type I and II. Anesthesiology 2000;92:75-83.
39. Finnerup NB, Biering-Sorensen F, Johannesen IL, Terkelsen AJ, Juhl GI, Kristensen AD, Sindrup SH, Bach FW, Jensen TS: Intravenous lidocaine relieves spinal cord injury pain: A randomized controlled trial. Anesthesiology 2005;102:1023-1030.
40. Kvarnstrom A, Karisten R, Quiding H, Gordh T: The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury. Acta Anaesthesiol Scand 2004; 48:498-506.
41. Cahana A, Carota A, Montadon ML, Annoni JM: The long-term effect of repeated intravenous lidocaine on central pain and possible correlation in positron emission tomography measurements. Anesth Analg 2004;98:1581-1584.
42. Keats AS, D'Alessandro G, Beecher HK: A controlled study of pain relief by intravenous procaine. JAMA 1951; 147:1761-1763.
43. Bartlett EE, Hutaserani O: Xylocaine for the relief of postoperative pain. Anesth Analg 1961;40:296-304.
44. Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, Hering W: Perioperative intravenous lidocaine has preventative effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg 2004;98:1050-1055.
45. Groudine SB, Fisher HA, Kaufman RP, Patel MK, Wilkins LJ, Mehta SA, Lumb PD: Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg 1998;86:235-239.
46. Kuo CP, Jao KM, Wong CS, Yeh CC, Sheen MJ, Wu CT: Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth 2006;4:640-646.
47. Bennett MI, Tai YM: Intravenous lignocaine in the management of primary fibromyalgia syndrome. Int J Clin Pharm Res 1995;15:115-119.
48. Raphael JH, Southall JL, Treharne GJ, Kitas GD: Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. BMC Musculoskelet Disord 2002; 3:1-8.
49. Wu CL, Tella P, Staats PS, Vaslav R, Kazim DA, Wesselmann U, Raja SN: Analgesic effects of intravenous lidocaine and morphine on postamputation pain: A randomized double-blind, active placebo-controlled, crossover trial. Anesthesiology 2002;96:841-848.
50. Jösson A, Cassuto J, Hanson B: Inhibition of burn pain by intravenous lignocaine infusion. Lancet 1991;338:151-152.
51. Hand PJ, Stark RJ: Intravenous lignocaine infusions for severe chronic daily headache. Med J Aust 2000;172:157-159.
52. Williams DR, Stark RJ: Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalgia 2003;23:963-971.
53. Peleg R, Shvartzman P: Low-dose intravenous lidocaine as treatment for proctalgia fugax. Reg Anesth Pain Med 2002;27:97-99.
54. Galer BS, Harle J, Rowbotham MC: Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: A prospective study. J Pain Symptom Manage 1996;12:161-167.
55. Wilson RA, Soei LK, Bezstarosti K, Lamers JM, Verdouw PD: Negative inotropy of lidocaine: possible biochemical mechanisms. Eur Heart J 1993;14:284-289.
56. Pankucsi C, Varrô A, Nánási PP: Three distinct components of the negative inotropic action of lidocaine in dog Purkinje fiber. Gen Pharmacol 1996;27:69-71.
57. Matos L, Hankoczy J, Torok E: Effects of lidocaine on myocardial function and on isoprenaline-induced circulatory changes in man. Int J Clin Pharmacol 1976;14:119-125.
58. Matsumura N, Matsumura H, Abiko Y: Effect of lidocaine on the myocardial acidosis induced by coronary artery occlusion in dogs. J Pharmacol Exp Ther 1987;242:1114-1119.
59. Gee D, Wilson R, Angello D: Acute effect of lidocaine on coronary blood flow and myocardial function. Angiology 1990;41:30-35.
60. Fujita Y, Endoh S, Yasukawa T, Sari A: Lidocaine increases the ventricular fibrillation threshold during bupivicaine-induced cardiotoxicity in pigs. Br J Anaesth 1998; 80:218-222.
61. Burney RG, Di Fazio CA, Peach MJ, Petrie KA, Silvester MJ: Anti-arrhythmic effects of lidocaine metabolites. Am Heart J 1974;88:765-769.
62. Furukawa T, Koumi S, Sakakibara Y, Singer DH, Jia H, Arentzen CE, Backer CL, Wasserstrom JA: An analysis of lidocaine block of sodium current in isolated human atrial and ventricular myocytes. J Mol Cell Cardiol 1995;27: 831-846.